1.The 1998, 1999 Patterns of Care Study for Breast Irradiation after Mastectomy in Korea.
Ki Chang KEUM ; Su Jung SHIM ; Ik Jae LEE ; Won PARK ; Sang wook LEE ; Hyun Soo SHIN ; Eun Ji CHUNG ; Eui Kyu CHIE ; Il Han KIM ; Do Hoon OH ; Sung Whan HA ; Hyung Sik LEE ; Sung Ja AHN ; Moon June CHO ; Juhn Kyu LOH ; Kyung Ran PARK ; Doo Ho CHOI ; Myung Za LEE ; Ki Jung AHN ; Won Dong KIM ; Bo Kyoung KIM ; Mison CHUN ; Jin Hee KIM ; Chang Ok SUH
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2007;25(1):7-15
PURPOSE: To determine the patterns of evaluation and treatment in patients with breast cancer after mastectomy and treated with radiotherapy. A nationwide study was performed with the goal of improving radiotherapy treatment. MATERIALS AND METHODS: A web-based database system for the Korean Patterns of Care Study (PCS) for 6 common cancers was developed. Randomly selected records of 286 eligible patients treated between 1998 and 1999 from 17 hospitals were reviewed. RESULTS: The ages of the study patients ranged from 20 to 80 years (median age 44 years). The pathologic T stage by the AJCC was T1 in 9.7% of the cases, T2 in 59.2% of the cases, T3 in 25.6% of the cases, and T4 in 5.3% of the cases. For analysis of nodal involvement, N0 was 7.3%, N1 was 14%, N2 was 38.8%, and N3 was 38.5% of the cases. The AJCC stage was stage I in 0.7% of the cases, stage IIa in 3.8% of the cases, stage IIb in 9.8% of the cases, stage IIIa in 43% of the cases, stage IIIb in 2.8% of the cases, and IIIc in 38.5% of the cases. There were various sequences of chemotherapy and radiotherapy after mastectomy. Mastectomy and chemotherapy followed by radiotherapy was the most commonly performed sequence in 47% of the cases. Mastectomy, chemotherapy, and radiotherapy followed by additional chemotherapy was performed in 35% of the cases, and neoadjuvant chemoradiotherapy was performed in 12.5% of the cases. The radiotherapy volume was chest wall only in 5.6% of the cases. The volume was chest wall and supraclavicular fossa (SCL) in 20.3% of the cases; chest wall, SCL and internal mammary lymph node (IMN) in 27.6% of the cases; chest wall, SCL and posterior axillary lymph node in 25.9% of the cases; chest wall, SCL, IMN, and posterior axillary lymph node in 19.9% of the cases. Two patients received IMN only. The method of chest wall irradiation was tangential field in 57.3% of the cases and electron beam in 42% of the cases. A bolus for the chest wall was used in 54.8% of the tangential field cases and 52.5% of the electron beam cases. The radiation dose to the chest wall was 45~59.4 Gy (median 50.4 Gy), to the SCL was 45~59.4 Gy (median 50.4 Gy), and to the PAB was 4.8~38.8 Gy, (median 9 Gy) CONCLUSION: Different and various treatment methods were used for radiotherapy of the breast cancer patients after mastectomy in each hospital. Most of treatment methods varied in the irradiation of the chest wall. A separate analysis for the details of radiotherapy planning also needs to be followed and the outcome of treatment is needed in order to evaluate the different processes.
Breast Neoplasms
;
Breast*
;
Chemoradiotherapy
;
Drug Therapy
;
Humans
;
Korea*
;
Lymph Nodes
;
Mastectomy*
;
Mastectomy, Radical
;
Radiotherapy
;
Thoracic Wall
2.Effectiveness of Fentanyl Transdermal Patch (Fentanyl-TTS, Durogegic(R)) for Radiotherapy Induced Pain and Cancer Pain: Multi-center Trial.
Seong Soo SHIN ; Seung Jae HUH ; Eun Kyung CHOI ; Jong Hoon KIM ; Seung Do AHN ; Sang Wook LEE ; Yeun Sil KIM ; Kyu Chan LEE ; Chang Geol LEE ; John JK LOH ; Mison CHUN ; Young Teak OH ; Ok Bae KIM ; Jin Hee KIM ; Chul Yong KIM ; Dae Sik YANG ; Woo Yoon PARK ; Bo Kyoung KIM ; Heung Lae CHO ; Ki Jung AHN ; Jong Young LEE ; Seon Min YUN ; Yong Chan AHN ; Do Hoon LIM ; Won PARK ; Ki Moon KANG ; Hong Gyun WU ; Hyun Soo SHIN ; Seong Soon JANG ; Eun Seog KIM ; Byung Sik NA ; Woong Ki JUNG ; Sung Ja AHN ; Taek Keun NAM ; Yong Ho KIM ; MI Hee SONG ; Sang Mo YUN ; Chul Seung KAY ; Ji Won YEI ; Suk Won PARK ; Seon Woo KIM
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2006;24(4):263-271
PURPOSE: To evaluate the effectiveness and safety of fentanyl-TTS in the management of radiotherapy induced acute pain and cancer pain treated with radiotherapy. MATERIALS AND METHODS: Our study was open labelled prospective phase IV multi-center study. the study population included patients with more 4 numeric rating scale(NRS) score pain although managed with other analgesics or more than 6 NRS score pain without analgesics. Patients divided into two groups; patients with radiotherapy induced pain (Group A) and patients with cancer pain treated with radiotherapy (Group B). All patients received 25 ug/hr of fentanyl transdermal patch. Primary end point was pain relief; second end points were change in patient quality of life, a degree of satisfaction for patients and clinician, side effects. RESULTS: Between March 2005 and June 2005, 312 patients from 26 participating institutes were registered, but 249 patients completed this study. Total number of patients in each group was 185 in Group A, 64 in Group B. Mean age was 60 years and male to female ratio was 76:24. Severe pain NRS score at 2 weeks after the application of fentanyl was decreased from 7.03 to 4.01, p=0.003. There was a significant improvement in insomnia, social functioning, and quality of life. A degree of satisfaction for patients and clinician was very high. The most common reasons of patients' satisfactions was good pain control. Ninety six patients reported side effect. Nausea was the most common side effect. There was no serious side effect. CONCLUSION: Fentanyl-TTS was effective in both relieving pain with good tolerability and improving the quality of life for patients with radiotherapy induced acute pain and cancer pain treated with radiotherapy. The satisfaction of the patients and doctors was good. There was no major side effect.
Academies and Institutes
;
Acute Pain
;
Analgesics
;
Female
;
Fentanyl*
;
Humans
;
Male
;
Nausea
;
Prospective Studies
;
Quality of Life
;
Radiotherapy*
;
Sleep Initiation and Maintenance Disorders
;
Transdermal Patch*
3.Clinical Charicteristics of Primary Lung Cancer Patients in a Tertiary Hospital.
Jeong Seon RYU ; Hun Jae LEE ; Jong Han LEEM ; Lucia KIM ; Kyung Hee LEE ; Jae Hwa CHO ; Young Han YOON ; Seung Min KWAK ; Hong Lyeol LEE ; Kwang Ho KIM ; John Kyu LOH ; Soo Kyung JUNG
Tuberculosis and Respiratory Diseases 2006;60(3):321-329
BACKGROUND: To evaluate the clinical characteristics of lung cancer patients in Korea, where there is a higher number of smokers than in Western countries. METHODS: A retrospective study was performed on 1655 lung cancer patients, who were diagnosed at a university hospital between September 1996 and August 2005. Age, gender, cell types and clinical stage were analysed. Of 941 patients, who responded to a questionnaire at the time of diagnosis, the smoking habits, occupational history, family history of lung cancer in the first-degree relatives, coexisting diseases (diabetes mellitus and cardiovascular disease), body weight loss, ECOG performance status and presenting symptoms, were examined prospectively. In addition, coexisting diseases including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and active pulmonary tuberculosis were evaluated. RESULTS: Of the 1655 patients, the male to females ratio was 3.6. Squamous cell carcinoma was the most common cancer whereas adenocarcinoma was more common in lifetime nonsmokers or women. 19.9% of the patients were non smokers and 80.1% ever smokers. Since 2000, there was an increase in the incidence of adenocarcinoma with a corresponding decrease in the incidence of squamous cell carcinoma. 6.2% of patients were asymptomatic. A coincident diagnosis of chronic obstructive pulmonary disease, cardiovascular disease, diabetes mellitus, active pulmonary tuberculosis, and idiopathic pulmonary fibrosis was made in: 44.1%, 22.2%, 10.7%, 3.9%, and 1.6% of patients, respectively. A positive family history of lung cancer in the first-degree relatives was identified in 4.4% of patients. An occupational history relevant to lung cancer was identified in 12.2% of patients. CONCLUSION: There is a high proportion of cigarette smokers in Korean lung cancer patients. The most common cell type was squamous cell carcinoma. However, a more detailed, prospective study of the clinical characteristics will be needed to better characterize lung cancer in Korea.
Adenocarcinoma
;
Body Weight
;
Carcinoma, Squamous Cell
;
Cardiovascular Diseases
;
Diabetes Mellitus
;
Diagnosis
;
Female
;
Humans
;
Idiopathic Pulmonary Fibrosis
;
Incidence
;
Korea
;
Lung Neoplasms*
;
Lung*
;
Male
;
Prospective Studies
;
Pulmonary Disease, Chronic Obstructive
;
Surveys and Questionnaires
;
Retrospective Studies
;
Smoke
;
Smoking
;
Tertiary Care Centers*
;
Tobacco Products
;
Tuberculosis, Pulmonary
4.The National Survey of Breast Cancer Treatment Pattern in Korea (1998): The Use of Breast-Conserving Treatment.
Hyun Soo SHIN ; Hyung Sik LEE ; Sei Kyung CHANG ; Eun Ji CHUNG ; Jin Hee KIM ; Yoon Kyung OH ; Mi Sun CHUN ; Seung Jae HUH ; John Jun Kyu LOH ; Chang Ok SUH
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2004;22(3):184-191
PURPOSE: In order to improve the proper use of radiotherapy and breast-conserving treatment (BCT) in the management of breast cancer, current status of breast cancer treatment in Korea was surveyed nationwide and the use of BCT were evaluated. MATERIALS AND METHODS: Patients characteristics and treatment pattern of 1048 breast cancer patients from 27 institutions diagnosed between January, 1998 and June, 1998 were analyzed. The incidence of receiving BCT was analyzed according to the stage, age, geography, type of hospital, and the availability of radiotherapy facility. RESULTS: Radical mastectomy was performed in 64.8% of total patients and 26% of patients received breast- conserving surgery (BCS). The proportions of patients receiving BCT were 47.5% in stage 0, 54.4% in stage I, and 20.3% in stage II. Some of the patients (6.6% of stage I, 10.1% of stage II and 66.7% of stage III) not received radiotherapy after BCS. Only 45% of stage III patients received post-operative radiotherapy after radical mastectomy. The proportion of patients receiving BCT was different according to the geography and availability of radiotherapy facilities. CONCLUSION: Radiotherapy was not fully used in the management of breast cancer, even in the patients received breast-conserving surgery. The proportion of the patients who received BCT was lower than the report of western countries. To improve the application of proper management of breast cancer, every efforts such as a training of physicians, public education, and improving accessibility of radiotherapy facilities should be done. The factors predicting receipt of BCT were accessibility of radiotherapy facility and geography. Also, periodic survey like current research is warranted.
Breast Neoplasms*
;
Breast*
;
Education
;
Geography
;
Humans
;
Incidence
;
Korea*
;
Mastectomy, Radical
;
Mastectomy, Segmental
;
Radiotherapy
5.A Case of Intramedullary Spinal Cord Metastasis From Non-small Cell Lung Cancer.
Sang Woo PARK ; Hyung Soo WI ; Hoon Soo KIM ; Jae Hwa CHO ; Hong Lyeol LEE ; John Kyu LOH ; Jeong Seon RYU
Tuberculosis and Respiratory Diseases 2002;52(6):627-632
Intramedullary spinal cord metastasis (ISCM) has rarely been reported in patients wit carcinomas. In about half the ISCM reported the primary origins are lung cancer, with small cell lung cancer responsible for almost all reported cases. Thus, ISCM from small cell lung cancer is relatively well documented, but ISCM from nonsmall cell lung cancer is rarely diagnosed prior to the patients' demise, so very little data about such patients is available. Spine MRI is the most sensitive technique for diagnosing ISCM. ISCM are now being encountered with increasing frequency due to the increasing survival rates of lung cancer patients, and the development of new imaging technique. We reported a case of an ISCM from non-small cell lung cancer with a brief review of the literature.
Carcinoma, Non-Small-Cell Lung*
;
Humans
;
Lung Neoplasms
;
Magnetic Resonance Imaging
;
Neoplasm Metastasis*
;
Small Cell Lung Carcinoma
;
Spinal Cord*
;
Spine
;
Survival Rate
6.A Case of Intramedullary Spinal Cord Metastasis From Non-small Cell Lung Cancer.
Sang Woo PARK ; Hyung Soo WI ; Hoon Soo KIM ; Jae Hwa CHO ; Hong Lyeol LEE ; John Kyu LOH ; Jeong Seon RYU
Tuberculosis and Respiratory Diseases 2002;52(6):627-632
Intramedullary spinal cord metastasis (ISCM) has rarely been reported in patients wit carcinomas. In about half the ISCM reported the primary origins are lung cancer, with small cell lung cancer responsible for almost all reported cases. Thus, ISCM from small cell lung cancer is relatively well documented, but ISCM from nonsmall cell lung cancer is rarely diagnosed prior to the patients' demise, so very little data about such patients is available. Spine MRI is the most sensitive technique for diagnosing ISCM. ISCM are now being encountered with increasing frequency due to the increasing survival rates of lung cancer patients, and the development of new imaging technique. We reported a case of an ISCM from non-small cell lung cancer with a brief review of the literature.
Carcinoma, Non-Small-Cell Lung*
;
Humans
;
Lung Neoplasms
;
Magnetic Resonance Imaging
;
Neoplasm Metastasis*
;
Small Cell Lung Carcinoma
;
Spinal Cord*
;
Spine
;
Survival Rate
7.Parotid Gland Sparing Radiotherapy Technique Using 3-D Conformal Radiotherapy for Nasopharyngeal Carcinoma.
Ji Hoon LIM ; Gwi Eon KIM ; Ki Chang KEUM ; Chang Ok SUH ; Sang Wook LEE ; Hee Chul PARK ; Jae Ho CHO ; Sang Hoon LEE ; Sei Kyung CHANG ; Juhn Kyu LOH
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2000;18(1):1-10
PURPOSE: Although using the high energy photon beam with conventional parallel-opposed beams radio-therapy for nasopharyngeal carcinoma, radiation-induced xerostomia is a troublesome problem for patient. We conducted this study to explore a new parotid gland sparing technique in 3-D conformal radiotherap (3-D CRT) in an effort to prevent the radiation-induced xerostomia. MATERIALS AND METHODS: We performed three different planning for four clinically node-negative naso-phar yngeal cancer patients with different location of tumor(intracranial extension, nasal cavity extension, oropharyngeal extension, parapharyngeal extension), and intercompared the plans. Total prescription dos <. Was 70.2 Gy to the isocenter, For plan-A, 2-D parallel opposing fields, a conventional radiotherapy technique, were employed. For plan-B, 2-D parallel opposing fields were used up until 54 Gy an < 3 afterwards 3-D non-coplanar beams were used. For plan-C, the new technique, 54 Gy was delivered b r 3-D conformal 3-port beams (AP and both lateral ports with wedge compensator; shielding both superficial lobes of parotid glands at the AP beam using BEV) from the beginning of the treatment and early spinal cord block (at 36 Gy) was performed. And bilateral posterio r necks were treated with electron after 36 Gy. After 54 Gy, non-coplanar beams were used for cone-down plan. We intercompared dose statistic; Dmax, Dmin, Dmean, D95, D05, V95, V05, Volume receiving 46 Gy) and dose volume histograms (DVH) of tumor and normal tissues and NTCP values of parotid glands for the above three plans. RESULTS: For all patients, the new technique (plan-C) was comparable or superior to the other plans in target volume isodose distribution and dose statistics and it has more homogenous target volume, coverage. The new technique was most superior to the other plans in parotid glands sparing (volume receiving 46 Gy: 100, 9 B, 69% for each plan-A, B and C). And it showed the lowest NTCP value of parotid glands in all patients (range of NTCP; 96-100%, 79-99%, 51-72% for each plan-A, B and C). CONCLUSION: We conclude that the new technique employing 3-D conformal radiotherapy at the beginning of radiotherapy and cone down using non-coplanar beams with early spinal cord block is highly recommended to spare parotid glands for node-negative nasopharygeal cancer patients.
Humans
;
Nasal Cavity
;
Neck
;
Parotid Gland*
;
Prescriptions
;
Radiotherapy*
;
Radiotherapy, Conformal*
;
Spinal Cord
;
Xerostomia
8.The Correlation between DNA Ploidy and the Clinicohistologic Findings in Colorectal Cancer.
Suk Ho LEE ; Hun Jung KIM ; Woo Chul KIM ; Young Kap CHO ; Jun Kyu LOH ; Ze Hong WOO ; Tae Sook HWANG
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2000;18(3):187-193
PURPOSE: DNA ploidy pattern was shown to correlate with several clinicohistologic findings in several tumors. Aim of this study was to evaluate the correlation of the clinicohistologic findings in colorectal cancer and the failure pattern in rectosigmoid cancer with DNA ploidy. MATERIALS AND METHODS: DNA flow cytometry using the Hedley methods on paraffin embedded specimen from 117 patients with colorectal cancers after curative resection was performed. We tried to find the correlation between DNA ploidy and various clinicohistologic findings. And then the correlation DNA ploidy and the failure pattern in 75 patients of rectosigmoid cancer was analized. RESULTS: Forty samples (34.2%) from tumors gave aneuploidy histogram. There was no significant difference in the frequency of DNA aneuploidy in terms of age, sex, depth of invasion, location and Dukes stage. But there was a significant correlation between DNA ploidy and the failure rates in Dukes stage B rectosigmoid cancer ( p=0.048). CONCLUSIONS: These findings suggest that DNA ploidy pattern shows the correlation with the treatment failure rates in Dukes stage B rectosigmoid, but not with many other clinicohistologic findings. However, more patients will be needed to disclose these findings.
Aneuploidy
;
Colorectal Neoplasms*
;
DNA*
;
Flow Cytometry
;
Humans
;
Paraffin
;
Ploidies*
;
Treatment Failure
9.Optimization of Dose Distribution for High Dose Rate Intraluminal Therapy.
Sung Sil CHU ; Gwi Eon KIM ; Juhn Kyu LOH
Journal of the Korean Society for Therapeutic Radiology 1994;12(2):243-252
The use of high dose rate remote afterloading system for the treatment of intraluminal lesions necessitates the need for a more accurate of dose distributions around the high intensity brachytherapy sources, doses are often prescribed to a distance of few centimeters from the linear source, and in this range the dose distribution is very difficult to assess. Accurated and optimized dose calculation with stable numerical algorithms by PC level computer was required to treatment intraluminal lesions by high dose rate brachytherapy system. The exposure rate from sources was calculated with Sievert integral and dose rate in tissue was calculated with Meisberger equation. An algorithm for generating a treatment plan with optimized dose distribution was developed for high dose rate intraluminal radiotherapy. The treatment volume becomes the locus of the constrained target surface points that is the specified radial distance from the source dwelling positions. The treatment target volume may be alternately outlined on a x-ray film of the implant dummy sources. The routine used a linear programming formulism to compute which dwell time at each position to irradiate the constrained dose rate at the target surface points whiles minimizing the total volume integrated dose to the patient. The exposure rate and the dose distribution to be confirmed the result of calculation with algorithm were measured with film dosimetry, TLD and small size ion chambers.
Brachytherapy
;
Film Dosimetry
;
Humans
;
Programming, Linear
;
Radiotherapy
;
X-Ray Film
10.The Role of the Postoperative Adjuvant Radiation Therapy to Primary Site in Rectal Cancer Patients with Synchronous Liver Metastasis.
Jin Sil SEONG ; Hyun Soo SHIN ; Hyung Sik LEE ; Gwi Eon KIM ; Chang Ok SUH ; John Kyu LOH ; Woo Cheol KIM ; Hong Ryull PYO
Journal of the Korean Society for Therapeutic Radiology 1993;11(1):103-108
Among the patients with rectal cancer who entered Yonsei University Hospital for management from Jan. 1980 to Dec. 1990, we selected 23 subjects who were received surgical resection of tumor in rectum, and who proved to have liver metastasis during the diagnostic work-up, at the time of the operation, or within 3 months after starting definitive treatment. With those subjects, we investigated the role of radiation therapy by comparison of the treatment results of the patients without radiation therapy (S group) with those of the patients with radiation therapy to the primary site (S+R group). The local control rates of S group and S+R group were 64% and 89%, and 2-year survival rates were 50% and 78%, respectively. Although there was not statistically meaningful difference, local control rate and 2-year survival rate were higher in the group with radiation therapy to primary site than that without radiation therapy. The 2-year survival rates of the case with resection of the liver and the case without it were 03.6% and 58.3% respectively, which was not statistically significant. Also, the 2-year survival rate of the case with sustained local control was higher than that of the case with local failure, which was statistically significant(70.5% and 16.7%, p<0.005). From the above results, it is thought that radiation therapy to the primary site might improve the local control rate even in the patients with liver metastasis, which seems to be correlated to the higher survival rate.
Humans
;
Liver*
;
Neoplasm Metastasis*
;
Radiotherapy
;
Rectal Neoplasms*
;
Rectum
;
Survival Rate

Result Analysis
Print
Save
E-mail